Pemetero 500 mg Injection contains Pemetrexed, an anti-cancer medication used primarily to treat non-small cell lung cancer(NSCLC) and malignant pleural mesothelioma.
| Composition | Pemetrexed |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 1 Injection in 1 Vial |
| Prescribed For | Lung Cancer |
| Expiry | December 2027 |
Sorafekast 200mg contains Sorafenib, a targeted cancer therapy used in the treatment of advanced liver cancer (Hepatocellular Carcinoma), kidney cancer (Renal Cell Carcinoma), and certain types of thyroid cancer.
| Composition | Sorafenib (200mg) |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | Liver Cancer, Kidney Cancer and Thyroid Cancer |
| Expiry | December 2027 |
Geftinat 250mg Tablet contains Gefitinib, a targeted cancer therapy used in the treatment of non-small cell lung cancer (NSCLC), especially in patients with EGFR gene mutations.
| Composition | Gefitinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets |
| Prescribed For | Lung Cancer |
| Expiry | December 2027 |
Cycokast 50mg Injection contains Cisplatin, a platinum-based chemotherapy drug used to treat various types of cancer, including bladder, ovarian, testicular, lung, and cervical cancers.
| Composition | Cisplatin |
| Manufacturer | Aprazer Healthcare Pvt ltd |
| Packing | 1 Vial |
| Prescribed For | Anti-cancer |
| Expiry | December 2027 |
Crizalk 250mg Capsule contains Crizotinib, a targeted cancer therapy used to treat patients with non-small cell lung cancer (NSCLC) that is positive for ALK (anaplastic lymphoma kinase) or ROS1 gene rearrangements.
| Composition | Crizotinib |
| Manufacturer | Pfizer Ltd |
| Packing | 60 Capsules |
| Prescribed For | Lung Cancer |
| Expiry | December 2027 |
Carbotero 450mg contains Carboplatin, a platinum-based chemotherapy drug. It is used to treat various types of cancer by damaging the DNA of cancer cells, preventing them from growing and dividing.
| Composition | Carboplatin |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 1 vial(s) of 45 ml |
| Prescribed For | Anticancer |
| Expiry | December 2027 |
Bevatas 400mg injection contains Bevacizumab, a monoclonal antibody used in the treatment of various types of cancers, including colorectal cancer, lung cancer, kidney cancer, ovarian cancer, and glioblastoma.
| Composition | Bevacizumab |
| Manufacturer | Intas Pharmaceuticals |
| Packing | 16.0 ml in 1 bottle |
| Prescribed For | Anti Cancer |
| Expiry | December 2027 |
Bdfoie 10 mg Capsule contains Lenvatinib, a targeted therapy used in the treatment of certain types of cancers including thyroid cancer, advanced renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer).
| Composition | Lenvatinib |
| Manufacturer | BDR Pharmaceuticals |
| Packing | 30 Capsules |
| Prescribed For | Thyroid, Kidney, Lung Cancer |
| Expiry | December 2027 |
Afanat 40mg contains Afatinib, a targeted cancer therapy used to treat non-small cell lung cancer (NSCLC) that is EGFR mutation-positive.
| Composition | Afatinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets |
| Prescribed For | Lung Cancer |
| Expiry | December 2027 |
